KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Leases: 2012-2024

Historic Current Leases for Exact Sciences (EXAS) over the last 9 years, with Dec 2024 value amounting to $27.4 million.

  • Exact Sciences' Current Leases rose 17.28% to $31.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 17.28%. This contributed to the annual value of $27.4 million for FY2024, which is 6.79% down from last year.
  • According to the latest figures from FY2024, Exact Sciences' Current Leases is $27.4 million, which was down 6.79% from $29.4 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Current Leases registered a high of $29.4 million during FY2023, and its lowest value of $11.5 million during FY2020.
  • Moreover, its 3-year median value for Current Leases was $28.4 million (2022), whereas its average is $28.4 million.
  • In the last 5 years, Exact Sciences' Current Leases spiked by 71.39% in 2021 and then fell by 6.79% in 2024.
  • Yearly analysis of 5 years shows Exact Sciences' Current Leases stood at $11.5 million in 2020, then soared by 71.39% to $19.7 million in 2021, then skyrocketed by 44.09% to $28.4 million in 2022, then increased by 3.52% to $29.4 million in 2023, then declined by 6.79% to $27.4 million in 2024.